About Maruho｜News Release

2012.04.02: Maruho Establishes New Subsidiary in London, UK (PDF:17KB)
2012.02.14: Maruho acquires Cutanea Life Sciences, Inc., U.S.A. Cutanea to become a wholly-owned subsidiary of Maruho. (PDF:30KB)

2011.10.03: Maruho Establishes New Subsidiary in the U.S.A. (PDF:16KB)
2011.05.16: Maruho Funds Chemiderm to Sponsor Research Program at Harvard (PDF:27KB)
2011.04.27: Dainippon Sumitomo Pharma and Maruho Enter into a License Agreement for a Novel Topical Analgesic Drug (PDF:27KB)
2011.03.02: Hokunalin® Tape (tulobuterol patch), a long-acting transdermal bronchodilator, is now in new packages printed with the content on the tape surface and the barcode on the pouch (PDF:330KB)

2010.12.06: Marketing Collaboration on Protopic®Ointment for Treatment of Atopic Dermatitis in Japan (PDF:21KB)
2010.11.12: Maruho founds the Maruho Prize.
“To clinical dermatologists contributed to development the dermatology.” (PDF:14KB)
2010.03.06: Maruho received Gold Triangle Awards 2010 by American Academy of Dermatology. This award recognaizes Maruho Derma Report Issue #3 "Vitiligo Advancements" for raising public awareness of dermatologic issues.(in more detail)

2008.11.28: Approval of a New Indication for Oxarol Ointment/Lotion (nonproprietary name: maxacalcitol), Psoriasis Vulgaris Treatment Topical Products Containing Active Vitamin D3, for Extended Treatment of Palmoplantar Pustulosis(PDF:39KB)

2007.12.06: Maruho received Porter Prize 2007 for Unique Strategies, Innovation and Management(in more detail)
2007.11.29: Maruho honored with Mecenat Awards for Networking Haiku Poets
2007.06.15: Psoriasis Vulgaris Treatment Ethical Drug Topical Lotion Containing Active Vitamin D3 Launch of "Oxarol Lotion" (PDF:77KB)
2007.02.01: Transfer of Production and Sales Approval of Penles, an anesthetic patch --- Commencement of production and sales by Nitto Denko and Maruho (PDF:104KB)

2006.09.29: Announcement about the conclusion of commitment line agreement by syndicate financing system (PDF:51KB)
2006.08.21: An additional indication of "Stromectol Tablets 3mg" (basically indicated for strongyolidiasis) was approved by the Health Authorities of Japan for oral drug of scabies (PDF:79KB)
2006.06.07: Tanabe Seiyaku and Maruho Concluded a License Agreement of Novel Topical Agent "PDE4 Inhibitor" for Skin Diseases in Japan (PDF:45KB)
2006.05.22: Hokunalin Tape (tulobuterol patch), the world fs first long-acting transdermal bronchodilator, will include printing of "HOKUNALIN" on the tape surface (PDF:261KB)
2006.02.15: Merck & Co., Inc. and Maruho Co., Ltd. sign the distributorship agreement for an orphan drug indicated for strongyloidiasis [STROMECTOL Tablets 3mg] in Japan (PDF:76KB)
2006.01.05: Distributorship Agreement of "Falzy" (INN: felbinac) as an ethical transdermal antiphlogistic, analgesic agent between Saitama Daiichi Pharmaceutical Co.,Ltd. and Maruho Co.,Ltd concluded. (PDF:21KB)

2005.11.01: Maruho and SkyePharma Sign Development and Marketing Agreement for Novel Pain Control Agent DepoBupivacaine in Japan (PDF:125KB)
2005.10.31: Maruho and Toray Partner on Phase III Therapeutic for Dialysis Patients in Europe (PDF:25KB)
2005.03.31: Maruho, Toray Agree to Co-Develop and Market New Atopic Dermatitis Drug in Japan (PDF:74KB)